NEPHROPLUS749.20

Nephrocare Health Services Limited

· Pharma & Health
AnnualQuarterly₹ CrorePeersKRSNAASURAKSHAHEALTHX3BBLACKBIOMcap ₹7,517 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY26
31/03/2026
Revenue from Operations998.8
Other Income24.5
Total Income1,023.4
Expenses
+ Cost of Materials Consumed226.8
+ Employee Benefit Expense171.8
+ Finance Costs60.2
+ Depreciation & Amortisation90.7
+ Other Expenses373.3
Total Expenses922.8
EBITDA227.0
EBIT136.3
Profit
PBT before Exceptional Items100.6
Pretax Income100.6
+ Current Tax35.6
+ Deferred Tax-14.9
Tax Expense20.6
+ Share of Associates & JVs-3.1
Net Income76.8
+ Net Income — Continuing Ops79.9
+ Other Comprehensive Income18.6
Total Comprehensive Income95.5
Net Income to Common76.8
Per Share
Basic EPS8.48
Diluted EPS8.10
Other Comprehensive Income — detail
+ Other Comprehensive Income18.6
+ Items NOT to be Reclassified to P&L0.1
+ Items to be Reclassified to P&L18.6
Comprehensive Income — Owners of Parent18.6
Per Share — as-filed variants
Basic EPS — Continuing Operations8.48
Diluted EPS — Continuing Operations8.10
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit772.1
Gross Margin %77.29
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)100.6
Net Income Adj (tax-effected)76.8
EPS Adj8.48
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value2.00
Paid Up Equity Capital20.1
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.